UNMC 2020 Lymphoma Study Group & Hematology Highlights: A Post ASH Review
New Therapies in AML: Is It Safe to Wait for Genomic Info to Start Therapy? How To Tailor the Therapy? Data on Targeting BCL-2 with Venetoclax
Comments 0
Login to view comments.
Click here to Login
